Biomedical Engineering Reference
In-Depth Information
Fig. 3
Chromatographic profiles of main tamoxifen phase I metabolites and some of its identified
glucuronidated metabolites in a plasma sample from a breast cancer patient receiving tamox-
ifen 20 mg BID (modified elution gradient from reference [
145
]). See legends in Fig.
2
for
abbreviations
